New Positron Emission Tomography (PET) Radioligand for Imaging σ-1 Receptors in Living Subjects

被引:83
作者
James, Michelle L. [1 ]
Shen, Bin [1 ]
Zavaleta, Cristina L. [1 ]
Nielsen, Carsten H. [1 ,2 ]
Mesangeau, Christophe [4 ]
Vuppala, Pradeep K. [3 ]
Chan, Carmel [1 ]
Avery, Bonnie A. [3 ]
Fishback, James A. [5 ]
Matsumoto, Rae R. [5 ]
Gambhir, Sanjiv S. [1 ]
McCurdy, Christopher R. [4 ]
Chin, Frederick T. [1 ]
机构
[1] Stanford Univ, Dept Radiol, Mol Imaging Program Stanford, Stanford, CA 94305 USA
[2] Univ Copenhagen, Rigshospitalet, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark
[3] Univ Mississippi, Dept Pharmaceut, University, MS 38677 USA
[4] Univ Mississippi, Dept Med Chem, University, MS 38677 USA
[5] W Virginia Univ, Sch Pharm, Dept Basic Pharmaceut Sci, Morgantown, WV 26506 USA
关键词
IN-VIVO EVALUATION; HIGHLY POTENT; HUMAN BRAIN; BINDING; DERIVATIVES; SA4503; LIGAND; COCAINE; AFFINITIES; ANTAGONIST;
D O I
10.1021/jm300371c
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
sigma-1 receptor (S1R) radioligands have the potential to detect and monitor various neurological diseases. Herein we report the synthesis, radiofluorination, and evaluation of a new S1R ligand 6-(3-fluoropropyl)-3-(2-(azepan-1-yl)ethyl)benzo[d]thiazol-2(3H)-one ([F-18]FTC-146, [F-18]13). [F-18]13 was synthesized by nucleophilic fluorination, affording a product with >99% radiochemical purity (RCP) and specific activity (SA) of 2.6 +/- 1.2 Ci/mu mol (n = 13) at end of synthesis (EOS). Positron emission tomography (PET) and ex vivo autoradiography studies of [F-18]13 in mice showed high uptake of the radioligand in S1R rich regions of the brain. Pretreatment with 1 mg/kg haloperidol (2), nonradioactive 13, or BD1047 (18) reduced the binding of [F-18]13 in the brain at 60 min by 80%, 82%, and 81%, respectively, suggesting that [F-18]13 accumulation in mouse brain represents specific binding to S1Rs. These results indicate that [F-18]13 is a promising candidate radiotracer for further evaluation as a tool for studying S1Rs in living subjects.
引用
收藏
页码:8272 / 8282
页数:11
相关论文
共 57 条
[1]   Methyl substitution on the piperidine ring of N-[ω-(6-methoxynaphthalen-1-yl)alkyl] derivatives as a probe for selective binding and activity at the σ1 receptor [J].
Berardi, F ;
Ferorelli, S ;
Abate, C ;
Pedone, MP ;
Colabufo, NA ;
Contino, M ;
Perrone, R .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (26) :8237-8244
[2]   A multireceptorial binding reinvestigation on an extended class of σ ligands:: N-[ω-(Indan-1-yl and tetralin-1-yl)alkyl] derivatives of 3,3-dimethylpiperidine reveal high affinities towards σ1 and EBP sites [J].
Berardi, F ;
Ferorelli, S ;
Colabufo, NA ;
Leopoldo, M ;
Perrone, R ;
Tortorella, V .
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (05) :1325-1335
[3]  
Collier TL, 2007, CURR PHARM DESIGN, V13, P51
[4]   Methods for determining n-octanol-water partition constants [J].
Danielsson, LG ;
Zhang, YH .
TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 1996, 15 (04) :188-196
[5]   Molecular imaging of σ receptors: synthesis and evaluation of the potent σ1 selective radioligand [18F]fluspidine [J].
Fischer, Steffen ;
Wiese, Christian ;
Maestrup, Eva Grosse ;
Hiller, Achim ;
Deuther-Conrad, Winnie ;
Scheunemann, Matthias ;
Schepmann, Dirk ;
Steinbach, Joerg ;
Wuensch, Bernhard ;
Brust, Peter .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (03) :540-551
[6]  
Fishback J. A., 2011, THESIS W VIRGINIA U
[7]   Synthesis and characterization of [3H]-SN56, a novel radioligand for the σ1 receptor [J].
Fishback, James A. ;
Mesangeau, Christophe ;
Poupaert, Jacques H. ;
McCurdy, Christopher R. ;
Matsumoto, Rae R. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 653 (1-3) :1-7
[8]   Release of [H-3]dopamine from guinea pig striatal slices is modulated by sigma(1) receptor agonists [J].
Gonzalez, GM ;
Werling, LL .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (04) :455-461
[9]   Sigma receptors: biology and therapeutic potential [J].
Guitart, X ;
Codony, X ;
Monroy, X .
PSYCHOPHARMACOLOGY, 2004, 174 (03) :301-319
[10]   σ1-receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine affords neuroprotection from focal ischemia with prolonged reperfusion [J].
Harukuni, I ;
Bhardwaj, A ;
Shaivitz, AB ;
DeVries, AC ;
London, ED ;
Hurn, PD ;
Traystman, RJ ;
Kirsch, JR .
STROKE, 2000, 31 (04) :976-981